A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic Migraine

Study Identifier
191622-148
CT.gov Identifier
NCT02147561
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Migraine - General
    • Study Drug
  • botulinum toxin Type A
    • Phase
    Phase 4
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Ethnically Korean with a diagnosis of chronic migraine
    Exclusion Criteria:
    * Anticipated need for botulinum toxin treatment for any reason other than chronic migraine during the study * Diagnosis of myasthenia gravis, Eaton-Lambert syndrome, or amyotrophic lateral sclerosis

    Protocol Summary

    This study will evaluate the safety and efficacy of BOTOX® treatment in Korean adults with chronic migraine.

    Study Locations

    Location
    Status
    Location
    Seoul, Republic of Korea
    Status
    Not applicable